Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
- Market Cap ₹ 38,895 Cr.
- Current Price ₹ 1,903
- High / Low ₹ 2,094 / 1,564
- Stock P/E 45.1
- Book Value ₹ 222
- Dividend Yield 0.24 %
- ROCE 15.5 %
- ROE 20.5 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 24.5%
Cons
- Stock is trading at 8.57 times its book value
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 4,890 | 5,483 | 7,896 | 9,072 | |
| 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,722 | 4,185 | 6,255 | 7,330 | |
| Operating Profit | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,168 | 1,298 | 1,641 | 1,742 |
| OPM % | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 24% | 24% | 21% | 19% |
| 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 73 | 80 | 37 | 56 | |
| Interest | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 163 | 266 | 285 |
| Depreciation | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 241 | 278 | 448 | 520 |
| Profit before tax | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 888 | 936 | 964 | 993 |
| Tax % | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | 16% | |
| -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 806 | 817 | |
| EPS in Rs | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 39.42 | 39.94 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 25% |
| 3 Years: | 20% |
| TTM: | 60% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 42% |
| 5 Years: | 155% |
| 3 Years: | 12% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 29% |
| 3 Years: | 23% |
| 1 Year: | 5% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 26% |
| 3 Years: | 25% |
| Last Year: | 21% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,422 | 4,333 |
| 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 2,428 | 5,858 | |
| 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,216 | 2,088 | |
| Total Liabilities | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 12,482 |
| 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 | 7,796 | |
| CWIP | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 | 292 |
| Investments | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 | 573 |
| 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,835 | 3,822 | |
| Total Assets | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 12,482 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | 986 | 1,621 | |
| -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | -1,325 | -3,648 | |
| 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 488 | 544 | 2,340 | |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 7 | -2 | 59 | -4 | 97 | 205 | 313 |
| Free Cash Flow | -15 | 86 | 85 | -20 | 129 | 329 | 235 | 235 | 563 | 99 | -93 | 753 |
| CFO/OP | 78% | 116% | 108% | 100% | 113% | 117% | 133% | 83% | 119% | 99% | 86% | 108% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 | 30 |
| Inventory Days | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 44 | 40 | 42 |
| Days Payable | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 214 | 185 | 248 |
| Cash Conversion Cycle | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -138 | -108 | -176 |
| Working Capital Days | -30 | -12 | -11 | -10 | -10 | -22 | -38 | -16 | -25 | -30 | -17 | -19 |
| ROCE % | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 26% | 21% | 16% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cayman Hospital Revenues (HCCI + EICL) USD Mn ・Standalone data |
|
||||||||||
| ALOS (Average Length of Stay) - India Hospitals days ・Standalone data |
|||||||||||
| ARPOB (Average Revenue Per Operational Bed) - India Hospitals INR Mn per quarter ・Standalone data |
|||||||||||
| IP Footfalls (Discharges) - India Hospitals thousands ・Standalone data |
|||||||||||
| Operational Beds (Group) count |
|||||||||||
| OP Footfalls (Out-Patients) - India Hospitals thousands ・Standalone data |
|||||||||||
| Cayman Insurance Revenues (CIHL Gross Written Premium) USD Mn ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21h - Schedule of meet of investors to be held on August 06, 2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21h - Schedule of meet of investors to be held on August 07, 2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Audio recording of Q1 FY27 earnings call uploaded on August 03, 2026.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
2d - Investors presentation for the quarter ended June 30, 2026
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Newspaper publication for unaudited (standalone and consolidated) financial results for the quarter ended June 30, 2026
Annual reports
-
Financial Year 2026
from bse
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
Concalls
-
Aug 2026TranscriptPPT REC
-
Jul 2026TranscriptAI SummaryPPT
-
Jun 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Nov 2025Transcript PPT
-
Oct 2025TranscriptAI SummaryPPT
-
Oct 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT REC
-
Aug 2025TranscriptAI SummaryPPT
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptAI SummaryPPT
-
Aug 2020Transcript PPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptAI SummaryPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptAI SummaryPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016TranscriptAI SummaryPPT
Hospital Portfolio[1]
- India: 18 owned/operated hospitals, 2 heart centers, 20 clinics and dialysis centers. Jammu unit is removed and is considered as a part of discontinued operation effective FY25.
- Cayman Islands: 2 hospital.
** - Total:** 42 healthcare facilities with 5,554 operational beds (including Cayman).